Statement Of Cash Flows [Abstract]
| Concept |
2023-01-01 to 2023-12-31 |
2022-01-01 to 2022-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for finance income (cost) |
270,000
USD
|
620,000
USD
|
| Cash flows from (used in) operations before changes in working capital |
162 768
USD
|
216 712
USD
|
| Increase (decrease) in working capital |
16 080
USD
|
6 455
USD
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
186,000
USD
|
1 769
USD
|
| Adjustments for gains (losses) on change in fair value of derivatives |
3,000
USD
|
1 558
USD
|
| Adjustments for gain (loss) on disposals, property, plant and equipment |
1 641
USD
|
162,000
USD
|
| Income taxes paid, classified as operating activities |
56 216
USD
|
44 964
USD
|
| Cash flows from (used in) investing activities [abstract] | ||
| Purchase of biological assets |
32 556
USD
|
29 429
USD
|
| Cash flows from (used in) financing activities [abstract] | ||
| Dividends paid to equity holders of parent, classified as financing activities |
33 765
USD
|
22 280
USD
|
| Dividends paid to non-controlling interests, classified as financing activities |
2 796
USD
|
1 720
USD
|
| Proceeds from sale or issue of treasury shares |
608,000
USD
|
109,000
USD
|
| Proceeds from non-current borrowings |
182,000
USD
|
755,000
USD
|
| Repayments of non-current borrowings |
18 528
USD
|
18 642
USD
|
| Proceeds from current borrowings |
17 671
USD
|
106,000
USD
|
| Repayments of current borrowings |
590,000
USD
|
7 154
USD
|